The last hurdle?

Gene Therapy

Volumn 12, Issue 12, 2005, Pages 956-957

  Nielsen, P E ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ISIS 3521; OBLIMERSEN; SMALL INTERFERING RNA; ANTISENSE OLIGONUCLEOTIDE; APOLIPOPROTEIN B;

CELL FUNCTION; CELL TRANSPORT; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; GENE DELIVERY SYSTEM; GENE TARGETING; GENE TECHNOLOGY; GENE THERAPY; HUMAN; MOLECULAR MECHANICS; NONHUMAN; NOTE; PRIORITY JOURNAL; RNA INTERFERENCE; RNA SPLICING; ANIMAL; ARTICLE; GENE SILENCING; GENE TRANSFER; GENETICS; LIVER; METABOLISM; METHODOLOGY; MOUSE;

ANIMALS; APOLIPOPROTEINS B; GENE SILENCING; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; LIVER; MICE; OLIGONUCLEOTIDES, ANTISENSE; RNA, SMALL INTERFERING;

EID: 21344474832     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302507     Document Type: Note

References (14)

1. Soutschek J et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 2004; 432: 173-178.
2. Goyenvalle A et al. Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping. Science 2004; 306: 1796-1799.
3. Stephenson ML, Zamecnik PC. Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide. Proc Natl Acad Sci USA 1978; 75: 285-288.
4. Kole R, Vacek M, Williams T. Modification of alternative splicing by antisense therapeutics. Oligonucleotides 2004; 14: 65-74; (review).
5. Hannon GJ, Rossi JJ. Unlocking the potential of the human genome with RNA interference. Nature 2004; 431: 371-378; (review).
6. Jarver P. Langel U. The use of cell-penetrating peptides as a tool for gene regulation. Drug Discov Today 2004; 9: 395-402.
7. Wender PA et al. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci USA 2000; 97: 13003-13008.
8. Gait MJ. Peptide-mediated cellular delivery of antisense oligonucleotides and their analogues. Cell Mol Life Sci 2003; 60: 844-853; (review).
9. Dragulescu-Andrasi A, Zhou P, He G, Ly DH. Cell-permeable GPNA with appropriate backbone stereochemistry and spacing binds sequence-specifically to RNA. Chem Commun 2005; 14: 244-246.
10. Püschl A et al. Peptide nucleic acids (PNAs) with a functional backbone. Tetrahedron Lett 1998; 39: 4707-4710.
11. Temsamani J, Vidal P. The use of cell-penetrating peptides for drug delivery. Drug Discov Today 2004; 9: 1012-1019; (review).
12. Kang SH, Cho MJ, Kole R. Up-regulation of luciferase gene expression with antisense oligonucleotides: implications and applications in functional assay development. Biochemistry 1998; 37: 6235-6239.
13. Sazani P et al. Systemically delivered antisense oligomers upregulate gene expression in mouse tissues. Nat Biotechnol 2002; 20: 1228-1233.
14. Linkletter BA, Szabo IE, Bruice TC. Solid-phase synthesis of oligopurine deoxynucleic guanidine (DNG) and analysis of binding with DNA oligomers. Nucleic Acids Res 2001; 29: 2370-2376.